Clinical Trial: CRF2 Agonist for the Treatment of Worsening Heart Failure

U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06815471) titled 'CRF2 Agonist for the Treatment of Worsening Heart Failure' on Feb. 03.

Brief Summary: This study assesses the effects of the investigational drug COR-1167 in subjects hospitalised due to worsening of heart failure (HF)

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Worsening Heart Failure

Intervention: DRUG: CRF2 agonist

28-day treatment

DRUG: Placebo

28-day treatment

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Corteria Pharmaceuticals

Published by HT Digital Content Services with permission from Health Daily Digest....